List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Urinalysis Market, 2021-2031, $ mn 18
Figure 5. Impact of COVID-19 on Business 21
Figure 6. Primary Drivers and Impact Factors of North America Urinalysis Market 23
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 26
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 10. Primary Restraints and Impact Factors of North America Urinalysis Market 29
Figure 11. Investment Opportunity Analysis 33
Figure 12. Porter’s Fiver Forces Analysis of North America Urinalysis Market 36
Figure 13. Breakdown of North America Urinalysis Market by Product Type, 2021-2031, % of Revenue 41
Figure 14. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 41
Figure 15. North America Urinalysis Market by Product Type: Instruments, 2021-2031, $ mn 42
Figure 16. North America Urinalysis Market by Instruments: Automated Analyzer, 2021-2031, $ mn 44
Figure 17. North America Urinalysis Market by Instruments: Semi-automated Analyzer, 2021-2031, $ mn 45
Figure 18. North America Urinalysis Market by Instruments: Point-of-Care Analyzer, 2021-2031, $ mn 46
Figure 19. North America Urinalysis Market by Product Type: Consumables, 2021-2031, $ mn 47
Figure 20. North America Urinalysis Market by Consumables: Reagents & Kits, 2021-2031, $ mn 48
Figure 21. North America Urinalysis Market by Consumables: Dipsticks, 2021-2031, $ mn 49
Figure 22. North America Urinalysis Market by Consumables: Disposables, 2021-2031, $ mn 50
Figure 23. Breakdown of North America Urinalysis Market by Test Type, 2021-2031, % of Sales Revenue 52
Figure 24. North America Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%) 52
Figure 25. North America Urinalysis Market by Test Type: Biochemical Test, 2021-2031, $ mn 53
Figure 26. North America Urinalysis Market by Test Type: Pregnancy & Fertility Test, 2021-2031, $ mn 54
Figure 27. North America Urinalysis Market by Test Type: Sediment Test, 2021-2031, $ mn 55
Figure 28. Breakdown of North America Urinalysis Market by Application, 2021-2031, % of Sales Revenue 57
Figure 29. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 57
Figure 30. North America Urinalysis Market by Application: Pregnancy & Fertility, 2021-2031, $ mn 58
Figure 31. North America Urinalysis Market by Application: Urinary Tract Infections (UTI), 2021-2031, $ mn 59
Figure 32. North America Urinalysis Market by Application: Diabetes, 2021-2031, $ mn 60
Figure 33. North America Urinalysis Market by Application: Kidney Diseases, 2021-2031, $ mn 61
Figure 34. North America Urinalysis Market by Application: Liver Diseases, 2021-2031, $ mn 62
Figure 35. North America Urinalysis Market by Application: Other Applications, 2021-2031, $ mn 63
Figure 36. Breakdown of North America Urinalysis Market by End User, 2021-2031, % of Revenue 65
Figure 37. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 65
Figure 38. North America Urinalysis Market by End User: Hospitals and Clinics, 2021-2031, $ mn 66
Figure 39. North America Urinalysis Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 67
Figure 40. North America Urinalysis Market by End User: Home Care Settings, 2021-2031, $ mn 68
Figure 41. North America Urinalysis Market by End User: Research Laboratories & Institutes, 2021-2031, $ mn 69
Figure 42. Breakdown of North America Urinalysis Market by Country, 2021 and 2031, % of Revenue 71
Figure 43. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 72
Figure 44. U.S. Urinalysis Market, 2021-2031, $ mn 74
Figure 45. Canada Urinalysis Market, 2021-2031, $ mn 76
Figure 46. Urinalysis Market in Mexico, 2021-2031, $ mn 78
Figure 47. Growth Stage of North America Urinalysis Industry over the Forecast Period 80
North America urinalysis market is projected to grow by 6.3% annually in the forecast period and reach $1,973.2 million by 2031, driven by the growing geriatric population, the prevalence of age-related diseases, the growing healthcare expenditure, and the advancing diagnostic technologies. Highlighted with 23 tables and 47 figures, this 99-page report “North America Urinalysis Market 2021-2031 by Product Type (Instruments, Consumables), Test Type (Biochemical, Pregnancy & Fertility, Sediment), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America urinalysis market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America urinalysis market in every aspect of the classification from perspectives of Product Type, Test Type, Application, End User, and Country. Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments o Automated Analyzer o Semi-automated Analyzer o Point-of-Care Analyzer • Consumables o Reagents & Kits o Dipsticks o Disposables Based on Test Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biochemical Test • Pregnancy & Fertility Test • Sediment Test By Applications, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pregnancy & Fertility • Urinary Tract Infections (UTI) • Diabetes • Kidney Diseases • Liver Diseases • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Diagnostic Laboratories • Home Care Settings • Research Laboratories & Institutes Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Test Type and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 77 Elektronika Kft. Abbott Laboratories Acon Laboratories Inc. Arkray Inc. Becton, Dickinson and Company Bio-Rad Laboratories Inc. Cardinal Health Inc. Danaher Corporation (Beckman Coulter Inc.) Eiken Chemical Co., Ltd. F Hoffmann-La Roche Ltd. Mindray Medical International Limited Quidel Corporation Siemens Healthineers AG Sysmex Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More